Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 61.5%
Negative

Neutral
GlobeNewsWire
3 days ago
Vertex to Announce First Quarter 2026 Financial Results on Thursday, May 7, 2026
KING OF PRUSSIA, Pa., April 13, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading provider of enterprise compliance technology for global commerce, today announced that it will release first quarter 2026 financial results before the market opens on Thursday, May 7, 2026. A conference call to discuss the results will be held at 8:30 a.m. Eastern Time that same day.
Vertex to Announce First Quarter 2026 Financial Results on Thursday, May 7, 2026
Neutral
GlobeNewsWire
22 days ago
VERTEX Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, March 25, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Vertex, Inc. (NASDAQ: VERX). The investigation focuses on Vertex's executive officers and whether investor losses may be recovered under federal securities laws.
VERTEX Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Neutral
The Motley Fool
1 month ago
Investment Firm Sheds 384,000 Shares of VERX Stock, According to Latest SEC Filing
Reduced holding by 384,415 shares; estimated transaction value of $8.32 million based on quarterly average price Quarter-end position value decreased by $26.01 million, reflecting both share sales and price changes Represents a 1.08% shift in 13F reportable assets under management (AUM) Post-trade, the fund owns 3,419,994 shares, valued at $68.30 million The position now accounts for 8.85% of AUM, which places it outside the fund's top five holdings
Investment Firm Sheds 384,000 Shares of VERX Stock, According to Latest SEC Filing
Positive
Barrons
1 month ago
Vertex Stock Jumps. What Wall Street Is Saying About Its Kidney Drug Trial.
The drug maker says its treatment of a rare kidney disease met its main goal in a late-stage trial.
Vertex Stock Jumps. What Wall Street Is Saying About Its Kidney Drug Trial.
Neutral
Seeking Alpha
1 month ago
Vertex, Inc. (VERX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Vertex, Inc. (VERX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Vertex, Inc. (VERX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Neutral
GlobeNewsWire
1 month ago
Vertex to Present at Upcoming Conferences
KING OF PRUSSIA, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX), a global provider of tax technology solutions, today announced that Chris Young, President and Chief Executive Officer, and John Schwab, Chief Financial Officer, will participate in a fireside chat at two upcoming conferences.
Vertex to Present at Upcoming Conferences
Positive
The Motley Fool
1 month ago
Why Vertex Stock Zoomed Almost 6% Higher on Thursday
It was the subject of a bullish analyst update. In that note, pundit Adam Hotchkiss reiterated his buy recommendation and lofty price target.
Why Vertex Stock Zoomed Almost 6% Higher on Thursday
Neutral
Investopedia
2 months ago
These 5 Software Stocks Could Double in Price This Year, Says Morgan Stanley
Software stocks may be down, but they're not out, according to analysts at Morgan Stanley.
These 5 Software Stocks Could Double in Price This Year, Says Morgan Stanley
Neutral
Seeking Alpha
2 months ago
Vertex, Inc. (VERX) Q4 2025 Earnings Call Transcript
Vertex, Inc. (VERX) Q4 2025 Earnings Call Transcript
Vertex, Inc. (VERX) Q4 2025 Earnings Call Transcript
Positive
Seeking Alpha
2 months ago
Vertex: Buy At Ultracheap Multiples, Product Is Safe From AI
Vertex has lost ~70% of its value despite steady growth and margin expansion, creating a compelling buy opportunity. VERX's FY26 guidance targets 10%-11% revenue growth and 23% adjusted EBITDA margin, trading at 2.9x EV/revenue and 12.5x EV/EBITDA. Fears of AI disruption are likely overstated given the complexity and risk of tax compliance, supporting Vertex's defensible niche.
Vertex: Buy At Ultracheap Multiples, Product Is Safe From AI